Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acino Holding AG

acino.swiss

Latest From Acino Holding AG

Takeda Sheds Products, Employees To Stada In $660m Move

Takeda offloads more assets as it focuses on core therapeutic areas and innovative drugs, this time a portfolio of products in emerging markets, with around 500 employees also affected.
Deals Emerging Markets

Who’s Hired? Biocon Appoints A New CEO

Biocon has appointed a new CEO, while Mundipharma and Acino have named regional managers. At the same time, Nelipak has also appointed a new CEO.

Appointments Strategy

Asia Deal Watch: Daiichi Sankyo Acquires Partial Asian Rights To Three Astellas Drugs

Daiichi Sankyo obtains rights to antiemetic Nasea and the anti-hypertension drugs Perdipine and Oldeca. Mitsubishi Tanabe licenses Asian rights to Viela’s inebilizumab for a rare eye disorder.

Deals Business Strategies

Takeda Offloads Emerging Market OTCs to Acino

Takeda is shedding some unwanted OTC assets in a number of emerging markets as part of its efforts to pay down debt and focus its portfolio following its acquisition of Shire. 
Deals Emerging Markets
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Transdermal
    • Generic Drugs
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Acino Pharma Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Acino Holding AG
  • Senior Management
  • Steffen Saltofte, CEO
    Gary Hughes, CFO
    Mario Ricard, COO
  • Contact Info
  • Acino Holding AG
    Phone: 44 555 22 00
    Thurgauerstrasse 36/38
    Zurich, CH-8050
    Switzerland
UsernamePublicRestriction

Register